# A10 Networks, Inc.: financial statements, quarterly

ATEN · NYSE · CIK 1580808 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aten.md) · [Financials](/companies/aten/financials.md) · [Filings](/companies/aten/filings.md) · [Insiders](/companies/aten/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aten/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [57.8](/filings/0001580808-24-000120.md) | [70.4 d](/filings/0001580808-26-000014.md) | [60.7](/filings/0001580808-25-000075.md) | [60.1](/filings/0001580808-25-000099.md) | [66.7](/filings/0001580808-25-000111.md) | [74.2 d](/filings/0001580808-26-000014.md) | [66.1](/filings/0001580808-26-000032.md) | [69.4](/filings/0001580808-26-000045.md) | [74.7](/filings/0001580808-25-000111.md) | [80.4 d](/filings/0001580808-26-000014.md) | [75.0](/filings/0001580808-26-000032.md) | [80.1](/filings/0001580808-26-000045.md) |
| Cost of revenue | $m | [11.0](/filings/0001580808-24-000120.md) | [13.3 d](/filings/0001580808-26-000014.md) | [11.4](/filings/0001580808-25-000075.md) | [12.0](/filings/0001580808-25-000099.md) | [13.0](/filings/0001580808-25-000111.md) | [14.9 d](/filings/0001580808-26-000014.md) | [13.4](/filings/0001580808-26-000032.md) | [14.7](/filings/0001580808-26-000045.md) | [14.8](/filings/0001580808-25-000111.md) | [17.1 d](/filings/0001580808-26-000014.md) | [15.3](/filings/0001580808-26-000032.md) | [16.8](/filings/0001580808-26-000045.md) |
| Gross profit | $m | [46.8](/filings/0001580808-24-000120.md) | [57.1 d](/filings/0001580808-26-000014.md) | [49.2](/filings/0001580808-25-000075.md) | [48.1](/filings/0001580808-25-000099.md) | [53.7](/filings/0001580808-25-000111.md) | [59.3 d](/filings/0001580808-26-000014.md) | [52.7](/filings/0001580808-26-000032.md) | [54.7](/filings/0001580808-26-000045.md) | [59.9](/filings/0001580808-25-000111.md) | [63.3 d](/filings/0001580808-26-000014.md) | [59.7](/filings/0001580808-26-000032.md) | [63.4](/filings/0001580808-26-000045.md) |
| Research and development | $m | [17.6](/filings/0001580808-24-000120.md) | [12.0 d](/filings/0001580808-26-000014.md) | [14.1](/filings/0001580808-25-000075.md) | [14.7](/filings/0001580808-25-000099.md) | [15.7](/filings/0001580808-25-000111.md) | [13.2 d](/filings/0001580808-26-000014.md) | [15.9](/filings/0001580808-26-000032.md) | [16.3](/filings/0001580808-26-000045.md) | [18.4](/filings/0001580808-25-000111.md) | [18.6 d](/filings/0001580808-26-000014.md) | [19.0](/filings/0001580808-26-000032.md) | [21.2](/filings/0001580808-26-000045.md) |
| Operating income | $m | [2.2](/filings/0001580808-24-000120.md) | [18.0 d](/filings/0001580808-26-000014.md) | [7.2](/filings/0001580808-25-000075.md) | [7.9](/filings/0001580808-25-000099.md) | [10.4](/filings/0001580808-25-000111.md) | [18.4 d](/filings/0001580808-26-000014.md) | [8.8](/filings/0001580808-26-000032.md) | [10.3](/filings/0001580808-26-000045.md) | [13.0](/filings/0001580808-25-000111.md) | [15.1 d](/filings/0001580808-26-000014.md) | [13.0](/filings/0001580808-26-000032.md) | [9.0](/filings/0001580808-26-000045.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(1.5)](/filings/0001580808-24-000120.md) | [1.2 d](/filings/0001580808-26-000014.md) | [1.5](/filings/0001580808-25-000075.md) | [1.5](/filings/0001580808-25-000099.md) | [1.8](/filings/0001580808-25-000111.md) | [3.2 d](/filings/0001580808-26-000014.md) | [0.9](/filings/0001580808-26-000032.md) | [1.4](/filings/0001580808-26-000045.md) | [1.8](/filings/0001580808-25-000111.md) | [6.2 d](/filings/0001580808-26-000014.md) | [2.2](/filings/0001580808-26-000032.md) | [1.0](/filings/0001580808-26-000045.md) |
| Net income | $m | [6.5](/filings/0001580808-24-000120.md) | [17.9 d](/filings/0001580808-26-000014.md) | [9.7](/filings/0001580808-25-000075.md) | [9.5](/filings/0001580808-25-000099.md) | [12.6](/filings/0001580808-25-000111.md) | [18.3 d](/filings/0001580808-26-000014.md) | [9.5](/filings/0001580808-26-000032.md) | [10.5](/filings/0001580808-26-000045.md) | [12.2](/filings/0001580808-25-000111.md) | [9.9 d](/filings/0001580808-26-000014.md) | [12.0](/filings/0001580808-26-000032.md) | [8.9](/filings/0001580808-26-000045.md) |
| Diluted EPS | $ per share | [0.09](/filings/0001580808-24-000120.md) | not reported | [0.13](/filings/0001580808-25-000075.md) | [0.13](/filings/0001580808-25-000099.md) | [0.17](/filings/0001580808-25-000111.md) | not reported | [0.13](/filings/0001580808-26-000032.md) | [0.14](/filings/0001580808-26-000045.md) | [0.17](/filings/0001580808-25-000111.md) | not reported | [0.17](/filings/0001580808-26-000032.md) | [0.12](/filings/0001580808-26-000045.md) |
| Basic EPS | $ per share | [0.09](/filings/0001580808-24-000120.md) | not reported | [0.13](/filings/0001580808-25-000075.md) | [0.13](/filings/0001580808-25-000099.md) | [0.17](/filings/0001580808-25-000111.md) | not reported | [0.13](/filings/0001580808-26-000032.md) | [0.15](/filings/0001580808-26-000045.md) | [0.17](/filings/0001580808-25-000111.md) | not reported | [0.17](/filings/0001580808-26-000032.md) | [0.12](/filings/0001580808-26-000045.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [104](/filings/0001580808-23-000214.md) | [97.2](/filings/0001580808-24-000120.md) | [123](/filings/0001580808-24-000077.md) | [77.5](/filings/0001580808-24-000105.md) | [78.1](/filings/0001580808-24-000120.md) | [95.1](/filings/0001580808-25-000111.md) | [244](/filings/0001580808-25-000075.md) | [253](/filings/0001580808-25-000099.md) | [86.6](/filings/0001580808-25-000111.md) | [71.1](/filings/0001580808-26-000045.md) | [57.9](/filings/0001580808-26-000032.md) | [54.7](/filings/0001580808-26-000045.md) |
| Current assets | $m | [265](/filings/0001580808-23-000214.md) | [272](/filings/0001580808-25-000043.md) | [276](/filings/0001580808-24-000077.md) | [275](/filings/0001580808-24-000105.md) | [284](/filings/0001580808-24-000120.md) | [307](/filings/0001580808-26-000014.md) | [458](/filings/0001580808-25-000075.md) | [457](/filings/0001580808-25-000099.md) | [469](/filings/0001580808-25-000111.md) | [476](/filings/0001580808-26-000045.md) | [480](/filings/0001580808-26-000032.md) | [483](/filings/0001580808-26-000045.md) |
| Total assets | $m | [378](/filings/0001580808-23-000214.md) | [390](/filings/0001580808-25-000043.md) | [396](/filings/0001580808-24-000077.md) | [397](/filings/0001580808-24-000105.md) | [408](/filings/0001580808-24-000120.md) | [433](/filings/0001580808-26-000014.md) | [606](/filings/0001580808-25-000075.md) | [608](/filings/0001580808-25-000099.md) | [620](/filings/0001580808-25-000111.md) | [630](/filings/0001580808-26-000045.md) | [634](/filings/0001580808-26-000032.md) | [678](/filings/0001580808-26-000045.md) |
| Current liabilities | $m | [111](/filings/0001580808-23-000214.md) | [111](/filings/0001580808-25-000043.md) | [113](/filings/0001580808-24-000077.md) | [115](/filings/0001580808-24-000105.md) | [127](/filings/0001580808-24-000120.md) | [124](/filings/0001580808-26-000014.md) | [113](/filings/0001580808-25-000075.md) | [108](/filings/0001580808-25-000099.md) | [129](/filings/0001580808-25-000111.md) | [134](/filings/0001580808-26-000045.md) | [129](/filings/0001580808-26-000032.md) | [375](/filings/0001580808-26-000045.md) |
| Total liabilities | $m | [181](/filings/0001580808-23-000214.md) | [182](/filings/0001580808-25-000043.md) | [181](/filings/0001580808-24-000077.md) | [183](/filings/0001580808-24-000105.md) | [190](/filings/0001580808-24-000120.md) | [201](/filings/0001580808-26-000014.md) | [410](/filings/0001580808-25-000075.md) | [404](/filings/0001580808-25-000099.md) | [414](/filings/0001580808-25-000111.md) | [418](/filings/0001580808-26-000045.md) | [414](/filings/0001580808-26-000032.md) | [440](/filings/0001580808-26-000045.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001580808-26-000014.md) | [218](/filings/0001580808-25-000075.md) | [218](/filings/0001580808-25-000099.md) | [218](/filings/0001580808-25-000111.md) | [219](/filings/0001580808-26-000045.md) | [219](/filings/0001580808-26-000032.md) | [0.0](/filings/0001580808-26-000045.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001580808-26-000045.md) | not reported | [220](/filings/0001580808-26-000045.md) |
| Shareholders' equity | $m | [197](/filings/0001580808-24-000120.md) | [208](/filings/0001580808-26-000014.md) | [214](/filings/0001580808-25-000099.md) | [214](/filings/0001580808-25-000111.md) | [217](/filings/0001580808-25-000111.md) | [232](/filings/0001580808-26-000045.md) | [196](/filings/0001580808-26-000045.md) | [204](/filings/0001580808-26-000045.md) | [206](/filings/0001580808-25-000111.md) | [212](/filings/0001580808-26-000045.md) | [221](/filings/0001580808-26-000045.md) | [238](/filings/0001580808-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [23.1 d](/filings/0001580808-24-000120.md) | [2.7 d](/filings/0001580808-26-000014.md) | [32.4](/filings/0001580808-25-000075.md) | [12.2 d](/filings/0001580808-25-000099.md) | [20.1 d](/filings/0001580808-25-000111.md) | [25.7 d](/filings/0001580808-26-000014.md) | [17.2](/filings/0001580808-26-000032.md) | [22.2 d](/filings/0001580808-26-000045.md) | [22.8 d](/filings/0001580808-25-000111.md) | [22.7 d](/filings/0001580808-26-000014.md) | [2.2](/filings/0001580808-26-000032.md) | [29.1 d](/filings/0001580808-26-000045.md) |
| Capital expenditure | $m | [2.7 d](/filings/0001580808-24-000120.md) | [3.1 d](/filings/0001580808-26-000014.md) | [2.9](/filings/0001580808-25-000075.md) | [3.5 d](/filings/0001580808-25-000099.md) | [3.5 d](/filings/0001580808-25-000111.md) | [2.4 d](/filings/0001580808-26-000014.md) | [4.5](/filings/0001580808-26-000032.md) | [4.2 d](/filings/0001580808-26-000045.md) | [4.7 d](/filings/0001580808-25-000111.md) | [6.7 d](/filings/0001580808-26-000014.md) | [2.9](/filings/0001580808-26-000032.md) | [1.6 d](/filings/0001580808-26-000045.md) |
| Dividends paid | $m | [4.5 d](/filings/0001580808-24-000120.md) | [4.4 d](/filings/0001580808-26-000014.md) | [4.5](/filings/0001580808-25-000075.md) | [4.5 d](/filings/0001580808-25-000099.md) | [4.4 d](/filings/0001580808-25-000111.md) | [4.4 d](/filings/0001580808-26-000014.md) | [4.4](/filings/0001580808-26-000032.md) | [4.3 d](/filings/0001580808-26-000045.md) | [4.3 d](/filings/0001580808-25-000111.md) | [4.3 d](/filings/0001580808-26-000014.md) | [4.3](/filings/0001580808-26-000032.md) | [4.3 d](/filings/0001580808-26-000045.md) |
| Share repurchases | $m | [2.4 d](/filings/0001580808-24-000120.md) | [7.3 d](/filings/0001580808-26-000014.md) | [3.0](/filings/0001580808-25-000075.md) | [11.8 d](/filings/0001580808-25-000099.md) | [9.4 d](/filings/0001580808-25-000111.md) | [5.8 d](/filings/0001580808-26-000014.md) | [47.0](/filings/0001580808-26-000032.md) | [3.9 d](/filings/0001580808-26-000045.md) | [11.0 d](/filings/0001580808-25-000111.md) | [6.9 d](/filings/0001580808-26-000014.md) | [2.5](/filings/0001580808-26-000032.md) | [2.4 d](/filings/0001580808-26-000045.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [77.7](/filings/0001580808-23-000214.md) | [75.5](/filings/0001580808-24-000077.md) | [75.4](/filings/0001580808-24-000105.md) | [75.8](/filings/0001580808-24-000120.md) | [75.3](/filings/0001580808-25-000075.md) | [75.5](/filings/0001580808-25-000099.md) | [74.8](/filings/0001580808-25-000111.md) | [75.0](/filings/0001580808-26-000032.md) | [73.1](/filings/0001580808-26-000045.md) | [73.0](/filings/0001580808-25-000111.md) | [72.9](/filings/0001580808-26-000032.md) | [75.7](/filings/0001580808-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 72,609,021 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001580808-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.